About
2cureX develops IndiTreat®, a diagnostic platform that cultures patient-derived 3D tumor microtissues (tumoroids) to test drug sensitivity and provide personalized therapy recommendations for cancer treatment.
Explore 2cureX's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.